Biochemical basis of cell apoptosis

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 11, Issue 28, 2007, Pages 5566-5569

  Gu, Guo Xin ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; CASPASE 10; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; CYTOCHROME C; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FODRIN; GELSOLIN; P21 ACTIVATED KINASE 2; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN BID; PROTEIN MCL 1;

APOPTOSIS; CELL DEATH; ENZYME ACTIVATION; ENZYME STRUCTURE; GENE CONTROL; HUMAN; INFORMATION RETRIEVAL; MEDLINE; ONLINE SYSTEM; PROTEIN DOMAIN; PROTEIN FUNCTION; REVIEW;

EID: 34548763217     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999;96(2): 245-254
2. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26(4):239-257
3. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306
4. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996;87(2):171
5. Budihardjo I, Oliver H, Lutter M, et al. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999;15:269-290
6. Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004; 304(5672):843-846
7. Huo JX, Metz SA, Li GD. p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells. Cell Death Differ 2004;11(1):99-109
8. Pendergraft WF 3rd,Rudolph EH,Falk RJ,et al. Proteinase 3 sidesteps caspases and cleaves p21 (Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis. Kidney Int 2004;65(1):75-84
9. Thornberry NA,Rano TA,Peforson EP,et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997;272(29):17907-17911
10. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284 (5756): 555-556
11. Zhivotovsky B, Orrenius S. Caspase-2 function in response to DNA damage. Biochem Biophys Res Commun 2005;331(3):859-867
12. Liu X, Zou H, Slaughter C, et al. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997;89(2):175-184
13. Enari M, Sakahira H, Yokoyama H, et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391(6662):43-50
14. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998;391 (6662):96-99
15. Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 1996;135 (6 Pt 1):1441-1455
16. Buendia B, Santa-Maria A, Courvalin JC: Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis. J Cell Sci 1999;112 (Pt 11): 1743-1753
17. Kothakota S,Azuma T,Reinhard C,et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997;278(5336):294-298
18. Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997;276(5318):1571-1574
19. Aho S. Plakin proteins are coordinately cleaved during apoptosis but preferentially through the action of different caspases. Exp Dermatol 2004; 13(11):700-707
20. Sohn D, Schulze-Osthoff K, Janicke RU. Caspase-8 can be activated by interchain proteolysis without receptor-triggered dimerization during drug-induced apoptosis. J Biol Chem 2005;280(7):5267-5273
21. Berube C,Boucher LM,Ma W,et al. Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc Natl Acad Sci U S A 2005; 102(40):14314-14320
22. Tu S, McStay GP, Boucher LM,et al. In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nature Cell Biol 2006;8(1):72-80
23. Lin CF,Chen CL,Chang WT,et al. Sequential caspase-2 and caspase-8 activation upstream of mitochondria during ceramide and etoposide-induced apoptosis. J Biol Chem 2004;279(39):40755-40761
24. Baliga BC, Read SH, Kumar S. The biochemical mechanism of caspase-2 activation. Cell Death Differ 2004; 11(11):1234-1241
25. Scott CL, Schuler M, Marsden VS, et al. Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation. J Cell Biol 2004; 164(1):89-96
26. Hao Z, Duncan GS, Chang CC, Elia A, et al. Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell 2005; 121(4):579-591
27. Beere HM, Wolf BB, Cain K. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000;2(8): 469-475
28. Nakagawa T, Shimizu S,Watanabe T, et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005;434(7033): 652-658
29. Cafforio P, Dammacco F, Gernone A, et al. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 2005; 26(5): 883-891
30. Green DR. Apoptotic Pathways: Ten Minutes to Dead. Cell 2005; 121(5): 671-674
31. Huang B, Eberstadt M, Olejniczak ET, et al. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 1996;384 (6610): 638-641
32. Eberstadt M, Huang B,Chen Z,et al. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain.Nature 1998;392 (6679): 941-945
33. Zhou P, Chou J, Olea RS, et al. Solution structure of Apaf-1 CARD and its interaction with caspase-9 CARD: a structural basis for specific adaptor/caspase interaction. Proc Natl Acad Sci USA 1999;96 (20): 11265-11270
34. Heiser D, Labi V, Erlacher M, et al. The Bcl-2 protein family and its role in the development of neoplas tic disease. Exp Gerontol 2004;39(8): 1125-1135
35. Lin CF,Chen CL,Chang WT,et al. Bcl-2 rescues ceramide and etoposide-induced mitochondrial apoptosis through blockage of caspase-2 activation. J Biol Chem 2005;280(25): 23758-23765
36. Fan TJ, Han LH, Cong RS, et al. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 2005;37(11):719-727
37. Chinese source.
38. Johnson CR, Jarvis WD. Caspase-9 regulation: an update. Apoptosis 2004;9(4):423-427
39. Hu Y, Benedict MA, Wu D, et al. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 1998;95(8):4386-4391
40. Hausmann G, O'Reilly LA, van Driel R,et al. Pro-apoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-x(L). J Cell Biol 2000;149(3):623-634
41. McEleny KR, Coffey R, Morrissey C,et al. An antisense oligonucleotide to cIAP-1 sensitizes prostate cancer cells to fas and TNFalpha mediated apoptosis. Prostate 2004;59(4):419-425
42. Muchmore SW,Sattler M,Liang H,et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 1996;381 (6580):335-341
43. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399(6735):483-487
44. Loeffler M, Kroemer G. The mitochondrion in cell death control: certainties and incognita. Exp Cell Res 2000;256(1):19-26
45. Scaffidi C, Fulda S, Srinivasan A,et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17(6): 1675-1687
46. Shin S,Lee Y,Kim W,et al. Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 2005; 24(20):3532-3542
47. Kobayashi Y, Mori M, Naruto T, et al. Dynamic movement of cytochrome c from mitochondria into cytosol and peripheral circulation in massive hepatic cell injury. Pediatr Int 2004;46(6):685-692
48. Verhagen AM,Ekert PG,Pakusch M,et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000;101(2):43-53
49. Robertson GS, Crocker SJ, Nicholson DW, et al. Neuroprotection by the inhibition of apoptosis. Brain Pathol 2000;10(2):283-292
50. Nicholson DW. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nature Biotechnol 1996;14 (3): 297-301
51. Zheng TS, Hunot S, Kuida K, et al. Caspase knockouts: matters of life and death. Cell Death Differ 1999; 6(11):1043-1053
52. Wang J, Lenardo MJ. Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci 2000;(Pt 5):753-757
53. Miller LK. An exegesis of IAPs: salvation and surprises from BIR motifs. Trends Cell Biol 1999;9(8):323-328
54. De luyrenzi V, Melino G. Apoptosis, the little devil of death.Nature 2000; 406(6792):135-136